<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E833A22-66FB-41DB-BB4E-283D08AF9A6E"><gtr:id>7E833A22-66FB-41DB-BB4E-283D08AF9A6E</gtr:id><gtr:name>Janssen Research &amp; Development</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8FD2AECC-0F32-4049-9C11-30778D38EEEF"><gtr:id>8FD2AECC-0F32-4049-9C11-30778D38EEEF</gtr:id><gtr:name>University of Luxembourg</gtr:name><gtr:address><gtr:line1>University of Luxembourg</gtr:line1><gtr:line2>162A avenue de la Faiencerie</gtr:line2><gtr:postCode>L-1511</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D7900CE2-A312-427D-AB82-2F88341AE2B5"><gtr:id>D7900CE2-A312-427D-AB82-2F88341AE2B5</gtr:id><gtr:name>SomaLogic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E51352F4-DB07-4212-AB85-CCA2029FF337"><gtr:id>E51352F4-DB07-4212-AB85-CCA2029FF337</gtr:id><gtr:name>Amyloid imaging to prevent Alzheimer's disease (AMYPAD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58704C20-A72D-49C0-BE60-977383C307F5"><gtr:id>58704C20-A72D-49C0-BE60-977383C307F5</gtr:id><gtr:name>Araclon Biotech</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/42E115D6-74A7-41AB-8729-C3F169DB4ECC"><gtr:id>42E115D6-74A7-41AB-8729-C3F169DB4ECC</gtr:id><gtr:name>Ixico</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E833A22-66FB-41DB-BB4E-283D08AF9A6E"><gtr:id>7E833A22-66FB-41DB-BB4E-283D08AF9A6E</gtr:id><gtr:name>Janssen Research &amp; Development</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8FD2AECC-0F32-4049-9C11-30778D38EEEF"><gtr:id>8FD2AECC-0F32-4049-9C11-30778D38EEEF</gtr:id><gtr:name>University of Luxembourg</gtr:name><gtr:address><gtr:line1>University of Luxembourg</gtr:line1><gtr:line2>162A avenue de la Faiencerie</gtr:line2><gtr:postCode>L-1511</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D7900CE2-A312-427D-AB82-2F88341AE2B5"><gtr:id>D7900CE2-A312-427D-AB82-2F88341AE2B5</gtr:id><gtr:name>SomaLogic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E51352F4-DB07-4212-AB85-CCA2029FF337"><gtr:id>E51352F4-DB07-4212-AB85-CCA2029FF337</gtr:id><gtr:name>Amyloid imaging to prevent Alzheimer's disease (AMYPAD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58704C20-A72D-49C0-BE60-977383C307F5"><gtr:id>58704C20-A72D-49C0-BE60-977383C307F5</gtr:id><gtr:name>Araclon Biotech</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/42E115D6-74A7-41AB-8729-C3F169DB4ECC"><gtr:id>42E115D6-74A7-41AB-8729-C3F169DB4ECC</gtr:id><gtr:name>Ixico</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BC9C56EA-4DD4-465B-A008-0A598A608E40"><gtr:id>BC9C56EA-4DD4-465B-A008-0A598A608E40</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Matthews</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A64B614B-387F-4A87-8F08-18C3C2916676"><gtr:id>A64B614B-387F-4A87-8F08-18C3C2916676</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09717709-C72F-4D1D-A890-7310F654D410"><gtr:id>09717709-C72F-4D1D-A890-7310F654D410</gtr:id><gtr:firstName>Carol</gtr:firstName><gtr:surname>Brayne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8BE1E05D-66EC-4BC1-984E-A885E5880F7D"><gtr:id>8BE1E05D-66EC-4BC1-984E-A885E5880F7D</gtr:id><gtr:firstName>Marcus</gtr:firstName><gtr:surname>Richards</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7A46BA4B-96A3-426F-A462-0A99B3A8D601"><gtr:id>7A46BA4B-96A3-426F-A462-0A99B3A8D601</gtr:id><gtr:firstName>Cathie</gtr:firstName><gtr:surname>Sudlow</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E31A811E-4DC9-442C-8BCB-7E05986CFD98"><gtr:id>E31A811E-4DC9-442C-8BCB-7E05986CFD98</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Gallacher</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7BDAB136-9238-446B-9EE2-3CC6A8606FC5"><gtr:id>7BDAB136-9238-446B-9EE2-3CC6A8606FC5</gtr:id><gtr:firstName>Craig</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Ritchie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8087A3C3-09A8-4495-8205-03AF95BFFB0E"><gtr:id>8087A3C3-09A8-4495-8205-03AF95BFFB0E</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:surname>Manson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B8C6561-A7B1-4005-94C5-F62552C54593"><gtr:id>9B8C6561-A7B1-4005-94C5-F62552C54593</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Lovestone</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/788CCC41-829E-4273-863B-33B991E33E67"><gtr:id>788CCC41-829E-4273-863B-33B991E33E67</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Starr</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7D6560DD-5C24-443C-9C64-BC770B160A0A"><gtr:id>7D6560DD-5C24-443C-9C64-BC770B160A0A</gtr:id><gtr:firstName>Ronan</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Lyons</gtr:surname><gtr:orcidId>0000-0001-5225-000X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3F80F013-4083-41DC-A241-BB6959CDACAB"><gtr:id>3F80F013-4083-41DC-A241-BB6959CDACAB</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>J.</gtr:otherNames><gtr:surname>Deary</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/73771842-1F5F-417D-B3E9-1C95161A8FA9"><gtr:id>73771842-1F5F-417D-B3E9-1C95161A8FA9</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Fox</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5B264FD6-EE14-4E6D-B52A-BC7460F89146"><gtr:id>5B264FD6-EE14-4E6D-B52A-BC7460F89146</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Rossor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AA8AFD7A-1956-462F-941F-96D2F16657AC"><gtr:id>AA8AFD7A-1956-462F-941F-96D2F16657AC</gtr:id><gtr:firstName>Jonathan Mark</gtr:firstName><gtr:surname>Schott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL023784%2F1"><gtr:id>3F2C5996-14BB-47ED-A4E8-4AF4118D0FFB</gtr:id><gtr:title>UK Dementias Platform</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L023784/1</gtr:grantReference><gtr:abstractText>The UK Dementias Platform (UKDP) is a radically new approach to dementias research, bringing together data from around 2,000,000 study participants from 22 cohorts to try and discover the causes of dementia and to find out ways of slowing it down. The platform has been funded to the level of &amp;pound;4.5M and invited to apply for a further &amp;pound;7.5M. 

To achieve our goals of discovering the causes of dementia and finding out ways to slow it down, we will analyse data collected over many decades from throughout the UK to identify targets for drugs studies. 

We will also enrich strategically selected cohorts to provide resources for dementias research in general. This will involve finding out how the early dementia processes begin, how our genes affect our risk of dementia and where our body goes wrong in maintaining and repairing itself. 

There are many practical challenges involved in doing this work including knowing how to assess dementia in large studies where having everyone examined by a doctor would be prohibitively expensive. Another challenge is how to measure cognitive decline in the population as when people begin to decline they are frequently less motivated to do cognitive tests.

There are also important ethical issues surrounding this work and we have specific projects looking at ethical legal and social issues surrounding taking part in detailed measurement studies as well as in considering brain donation.

To help make an impact as soon as possible, we will work closely with industry partners who are best placed to turn basic scientific knowledge into effective therapies.

Even if we cannot cure dementia in the short term, it would count as a success if we found ways of slowing it down so that nobody need lose their dignity as they grew older.</gtr:abstractText><gtr:technicalSummary>The UK Dementias Platform (UKDP) is a radically new approach to dementias research, providing a highly efficient and cost-effective translation pipeline from basic discovery through to early phase trials (Fig 1). By combining the analytic and statistical power of &amp;gt;20 clinical and population cohorts representing 2M participants and creating a large readiness cohort, UKDP will create an optimal environment for basic discovery activities relevant to the clinical progression and human impact of dementia. Although UKDP is intended as a strategic and sustainable resource generating increasing scientific benefit over time, it will also deliver short and medium term benefits through the analysis of existing data, the enrichment of strategically selected cohorts, developing new ways of working with industry, and generating interest and further funding for dementias research generally.

A single portal informatics hub (funded in stage 1) will be used for integrating data from participating cohorts and triangulating evidence between cohorts. The stage 2 proposal focuses on providing strategic resources for EM by enriching strategically selected cohorts, addressing key methodological issues and pump-priming a programme of EM studies.

Further development of the platform is anticipated as the opportunities it provides are more widely understood. For example, predicated on the ability of the platform's ability to provide accurately risk stratification, MRC and NIHR have recently funded a deep and frequent Phenotyping (DFP) feasibility study with a view to providing a further &amp;pound;5M for the full study. The DFP project may be considered a stage 3 development of UKDP and is an example of how UKDP can be used to leverage further resource for dementias research.</gtr:technicalSummary><gtr:potentialImpactText>The platform will use several vehicles to deliver impact. 

These were described in stage 1. 

In summary:

For the academic community, in addition to the proposals mad in stage 1, we will develop a network of partnerships and operate a system of working groups to actively consult the UK academic community and world experts on the direction, technologies and collaborations of the platform. Our aim is to 1) base the science of the platform on the best information available, 2) create momentum in dementias research by being inclusive of, and synergistic with, other initiatives.

For industry, partnership discussions are already underway with exchanges of ides, interests and needs between academic and industry stakeholders. Industry have identified their need for access to conversion (early MVI to dementia cohorts and for experimental medicine studies to conform to regulatory requirements.

We remain committed to raising the profile of contemporary debate about dementia and its treatment. We wish to encourage a culture of commitment to solving this problem. By increasing awareness at all levels of society we intend to leverage resources for the platform and for dementia research in general, to increase awareness of the need for earlier interventions and better targeted treatment in general by health service providers and the public alike.

Engagement with the general public and with patients and carers is a very important part of our mission. This serves not only to communicate our research findings and their relevance but also to address such issues as stigma in society and the research culture in the NHS in relation to dementia and older people. In addition to using the platform web-site to communicate to the general public, we will also liaise with charities and advocate groups such as Age UK and the Alzheimer's Society to promote our work and findings and to engage them in shaping the work programme.

In addition we will have a dedicated free-phone number available 6 days a week and a communications officer at 50% FTE over 5 years whose responsibility is to develop and implement a communications and public engagement strategy.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-06-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>13148876</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Luxembourg</gtr:collaboratingOrganisation><gtr:country>Luxembourg, Grand Duchy of</gtr:country><gtr:department>Faculty of Science, Technology and Communication</gtr:department><gtr:description>Twinning: Centre PD</gtr:description><gtr:id>C9BA8499-3FE1-45E6-86CF-818D1BDBF506</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b443267e475.80758961-1</gtr:outcomeId><gtr:partnerContribution>Centre PD will share information on clinical cohorts, stem cells and neuropathology
Centre PD worked with us on the EU Twinning grant to facilitate OPDC clinical data base move from Open Clinica to Red Cap System</gtr:partnerContribution><gtr:piContribution>OPDC will share information on clinical cohorts, stem cells and neuropathology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Cognition and Brain Sciences Unit</gtr:department><gtr:description>In press: publication paper: Study Protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development. BMC Neurology 2017</gtr:description><gtr:id>2EB006C1-E8E6-413D-9DFB-E819AE923725</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c92857ba8817.94529795-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>Lane CAS, Parker T, Cash DM, Macpherson K, Donnachie E, Murray-Smith H, Barnes A, Barker S, Beasley D, Bras J, BrownD, Burgos N, Byford M, Cardoso J, Carvalho A, Collins J, De Vita E, Dickson J, Epie N, Espak M, Henley SMD, Hoskote C, Hutel M, Klimova J, Malone I, Markiewicz P, Melbourne A, Modat M, Schrag A, Shah A, Sharma N, Sudre S, Thomas D, Wong A, Zhang H, Hardy H, Zetterberg H, Ourselin S, Crutch SJ, Kuh D, Richards M, Fox NC, Schott JM. Study Protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development. BMC Neurology 2017</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DPUK Cambridge</gtr:description><gtr:id>E1A68741-F2FB-4516-B3EA-B8AD7F3E8579</gtr:id><gtr:impact>Development of a strong Dementia Stem Cell Network in DPUK</gtr:impact><gtr:outcomeId>58c95ed36e7743.93709019-1</gtr:outcomeId><gtr:partnerContribution>The ARUK Stem Cell Research Centre, Cambridge has standardised the use of the Opera Phenix and Nanostring Sprint instruments for QC in iPSC reprogramming and cproduction of cortical neurons. The Phenix is used for high-throughput imaging of pluripotency markers in patient-derived lines that are generated at the centre. The lab has established a method for routine characterisation of cortical neuron productions using the Nanostring digital gene expression platform. This will facilitate harmonisation of protocols between DPUK centres, and within the STEMBANCC consortium.

The imaging platform has been used to develop methods for production of human microglia from iPSCs, and to study cell biology in patient iPSC-derived microglia, focussing on TREM2 mutatiosn. In collaboration with Talisman Therapeutics and AstraZeneca, assays have been established to measure protein uptake in cortical neurons by live imaging.</gtr:partnerContribution><gtr:piContribution>Optimisation of high-content imaging protocols with Opera Phenix imager</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Alzheimer's Research UK Oxford Drug Discovery Institute</gtr:department><gtr:description>ODDI Phenotypic drug discovery in Parkinson's</gtr:description><gtr:id>86835A51-79BC-4255-80EB-04F0F01DF455</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b46693869f4.62354424-1</gtr:outcomeId><gtr:partnerContribution>Collaborative drug discovery project in Parkinson's</gtr:partnerContribution><gtr:piContribution>Collaborative drug discovery project in Parkinson's</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Astra Zeneca</gtr:department><gtr:description>Enhancing autophagy flux in Parkinson's disease</gtr:description><gtr:id>D5605DC2-1CDE-42CA-A2BA-F4E449642ADE</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b4715baa021.98296647-1</gtr:outcomeId><gtr:partnerContribution>Astra Zeneca to provide drug-like small molecules.</gtr:partnerContribution><gtr:piContribution>OPDC test drug like molecules in cellular models of Parkinson's</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>SomaLogic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DPUK industry partnership</gtr:description><gtr:id>C99CCA16-329C-4C7D-B32B-3DBD4849ACB2</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-5</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>AZ Medimmune</gtr:department><gtr:description>DPUK industry partnership</gtr:description><gtr:id>FB1C076E-73BA-4686-827D-B06B3C75C0BA</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-3</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ixico</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DPUK industry partnership</gtr:description><gtr:id>B60DA153-3232-4BCE-A31B-19B538F472E2</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-4</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>European Prevention of Alzheimers disease project (EPAD)</gtr:description><gtr:id>38668F05-9E91-4E5B-8041-5143D5FE3698</gtr:id><gtr:impact>Multi-disciplinary: clinicians, imagers, geneticists, statisticians, epidemiologists.</gtr:impact><gtr:outcomeId>58ca9adcafceb7.06958977-1</gtr:outcomeId><gtr:partnerContribution>European colleagues are also contributing towards the trials infrastructure and recruitment tot he EPAD longitudinal cohort study</gtr:partnerContribution><gtr:piContribution>DPUK is contributing towards the trials infrastructure and recruitment tot he EPAD longitudinal cohort study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Cognition and Brain Sciences Unit</gtr:department><gtr:description>Insight 46</gtr:description><gtr:id>63519C42-3118-48FE-B634-B6C3E94D45A4</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c91f046e2506.63552114-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>Collaborating with colleagues at the UCL MRC National Survey for Health and Development, Institute of Molecular Neuroscience, and Institute of Nuclear Medicine, Insight 46 is a major prospective two-time point (0, 12m) MRI, amyloid PET, clinical, biomarker and neuropsychological study of 500 members of the MRC National Survey for Health and Development 1946 birth cohort. This highly inter-disciplinary study involving UCL based epidemiologists, neurologists, imagers, clinical chemists, geneticists and statisticians aims to determine the earliest biomarker changes of AD, the contribution of genetic and life course influences on the development of late life cognitive impairment, and the optimal means of designing AD prevention studies. This &amp;gt;&amp;pound;5M project includes funding from ARUK, MRC Dementias Platform UK (WP4), Wolfson Foundation and Brain Research Trust, as well as industry contributions (~&amp;pound;850K, Eli Lilly). As well as coordinating the project (with Fox, Richards) I supervise a study manager, two clinical PhD students (Lane and Parker, a Wellcome Training Fellowship), and a study coordinator. The study is well underway, with &amp;gt;300 scaned; cross-sectional data will complete in October 2017; and longitudinal collection two years later.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical School</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>1BF30A82-F6C1-457F-953D-854D74084770</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-1</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Araclon Biotech</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>DPUK industry partnership</gtr:description><gtr:id>37EEADE8-C146-4ECB-8ED1-B05AB0C1F77F</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-6</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neurology and GI Centre of Excellence for Drug Discovery (CEDD) GSK</gtr:department><gtr:description>DPUK industry partnership</gtr:description><gtr:id>B5E0D618-2387-45E9-BC94-81D63BE47E33</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-1</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Janssen Research &amp; Development</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>DPUK industry partnership</gtr:description><gtr:id>B7383573-36B2-47CD-8CCA-6697720DDF17</gtr:id><gtr:impact>Please refer to the following link:

http://brain.oxfordjournals.org/content/138/12/3673</gtr:impact><gtr:outcomeId>56e1979d3879d9.85020183-2</gtr:outcomeId><gtr:partnerContribution>Expertise and technologies</gtr:partnerContribution><gtr:piContribution>The Dementias Platform UK provides a research infrastructure for developing new treatments for dementia</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biosciences</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>098DF9D0-344C-4132-8A7C-36476AC43750</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-3</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dementias Platform UK Stem Cell Partnership</gtr:description><gtr:id>36CE4780-8BE5-4152-BCBB-24652AC11C58</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b45b51fb5a9.91764435-2</gtr:outcomeId><gtr:partnerContribution>Members will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:partnerContribution><gtr:piContribution>OPDC will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC fellowship</gtr:description><gtr:id>9B09EF1B-00E5-4469-B17F-0DEDD38DE080</gtr:id><gtr:impact>1. To improve causal inference in mendelian randomization studies of dementia
2. To improve understanding of the genetic risk for dementia and trajectories of cognitive capabilities in aging
3. To identify modifiable risk factors that are related to dementia and cognitive decline</gtr:impact><gtr:outcomeId>58bfd406dcd3f3.36262709-1</gtr:outcomeId><gtr:partnerContribution>A researcher, Dr. Emma Anderson, who is a highly productive junior researcher</gtr:partnerContribution><gtr:piContribution>advice and training on genomic data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Dementias Platform UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DPUK Imaging Consortium</gtr:description><gtr:id>57D52931-8FAA-4789-AC4C-11EE943E3D6E</gtr:id><gtr:impact>Project recently commenced</gtr:impact><gtr:outcomeId>58b6c093363187.49850343-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>Sharing of Imaging protocols and data management structures</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Dementias Platform UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dementias Platform UK Stem Cell Partnership</gtr:description><gtr:id>6435DE72-CAF4-435A-BAAA-225FBC798D2D</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>588b45b51fb5a9.91764435-1</gtr:outcomeId><gtr:partnerContribution>Members will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:partnerContribution><gtr:piContribution>OPDC will share expertise and stem cell lines as part of DPUK Stem Cell Network</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Amyloid imaging to prevent Alzheimer's disease (AMYPAD)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>AMYPAD</gtr:description><gtr:id>87CE29AF-CD0B-4718-B45E-C917D67966CE</gtr:id><gtr:impact>Project recently commenced</gtr:impact><gtr:outcomeId>58b6c1084cdc30.03239376-1</gtr:outcomeId><gtr:partnerContribution>Design of protocols</gtr:partnerContribution><gtr:piContribution>JMS is UCL lead for AMYPAD at UCL - which has interdependencies with DPUK through EPAD</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Electrophysiology in iPSC neurons</gtr:description><gtr:id>558092FF-FF39-40BB-8DBD-29984C4A67BF</gtr:id><gtr:impact>Ongoing collaboration</gtr:impact><gtr:outcomeId>56f5c845b7a119.31522502-1</gtr:outcomeId><gtr:partnerContribution>Helped us to establish the technique</gtr:partnerContribution><gtr:piContribution>We have worked to establish electrophysiology analysis of iPSC-derived cortical neurons</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>5EAA0014-5BEB-43ED-9080-31E16360D349</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-5</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Dementia Platform (DPUK)</gtr:description><gtr:id>CD3F4595-C8E3-4927-BBBE-39F6454F208F</gtr:id><gtr:impact>The DPUK launched in Autumn 2014. It is directed by Dr John Gallacher at the University of Cardiff, together with an executive team of investigators drawn from seven universities (Cambridge, Edinburgh, Imperial College London (ICL), Oxford, Newcastle, University College London (UCL) and Swansea), including the UCL-based MRC Unit for Lifelong Health and Ageing. The clinical research infrastructure award links DPUK with further universities, Manchester and Bristol.</gtr:impact><gtr:outcomeId>54b7f9ab6daf86.48828432-1</gtr:outcomeId><gtr:partnerContribution>The MRC Dementias Platform UK (DPUK) is a &amp;pound;53M public-private partnership, developed and led by the Medical Research Council, to accelerate progress in, and open up, dementias research. The DPUK's aims are early detection, improved treatment and ultimately, prevention, of dementias.</gtr:partnerContribution><gtr:piContribution>Many OPDC members play a leading role in the DPUK. Richard Wade-Martins head the DPUK National Dementia Stem Cell Network, Simon Lovestone heads Informatics component and Clare MacKay leads on informatics analysis of imaging. Richard and Simon are on thr DPUK Executive Committee.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>Abeta functional assays</gtr:description><gtr:id>7251BBF8-E0C5-420C-8446-8A14884337F6</gtr:id><gtr:impact>Ongoing collaboration</gtr:impact><gtr:outcomeId>56f5c8c42f3029.64134096-1</gtr:outcomeId><gtr:partnerContribution>Collaborative development of assay</gtr:partnerContribution><gtr:piContribution>We have worked to develop improved in vitro analysis odf Abeta function</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Manchester Medical School</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>E753D432-DB78-4E93-9585-CD34340C2582</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-4</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:description>DPUK DSCN</gtr:description><gtr:id>5FF12F59-4456-44F9-9D17-FC5AED7B8E1E</gtr:id><gtr:impact>Collaborations and interactions</gtr:impact><gtr:outcomeId>569820580432f2.63481461-2</gtr:outcomeId><gtr:partnerContribution>Forming DPUK Dementia Stem Cell Network</gtr:partnerContribution><gtr:piContribution>Forming DPUK Dementia Stem Cell Network</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Westminster forum</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D2105CB7-EB09-45B1-8DC0-BFFE067574ED</gtr:id><gtr:impact>Advice for policymakers on dementia research.</gtr:impact><gtr:outcomeId>58c91f9b7688c4.04314219</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.westminsterforumprojects.co.uk/conference-diary</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MED-BIO: Links to Farr Institute and CIPHER. Presentation to MED-BIO MRC bioinformatics centre, London - 6/7/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7E8257B7-FD93-4871-BCD6-BA39D0143CC7</gtr:id><gtr:impact>MED-BIO: Links to Farr Institute and CIPHER. Presentation to MED-BIO MRC bioinformatics centre, London</gtr:impact><gtr:outcomeId>584ea96ee3bde2.45200769</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Network Open Morning</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CA4B67E2-F92F-4735-A04F-5E24BD52441F</gtr:id><gtr:impact>About 150-200 people attended a morning of talks from Oxford researchers, including presentations on using stem cells in dementia research.</gtr:impact><gtr:outcomeId>56ddf81ac9c108.30351651</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DPUK Cohort Engagement Seminar</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DFD0A1E8-9136-458C-ADA4-8E03F4F53C49</gtr:id><gtr:impact>The purpose of the Cohort Seminar is to provide an overview of the Dementias Platform UK, build relationships with cohorts and formally invite cohorts to be part of DPUK.</gtr:impact><gtr:outcomeId>56e986bdd69bf3.57387275</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/events/?yy=2016&amp;mm=1</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on UK Secure eResearch Platform (DPUK) - 24/11/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>60F1F299-DC27-47E4-BDF6-ED9D379F303B</gtr:id><gtr:impact>Presentation on UK Secure eResearch Platform (DPUK) at MRC meeting 'Managing the data life-cycle for stratified medicine', London</gtr:impact><gtr:outcomeId>564c7a2a92ca52.15124714</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary speaker: Cypriot Neurological Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2481F966-3E9F-47CE-AEE1-80A6006CB44C</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c920f88479b5.76283040</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at MRC organised conference: Strengthening the UK's capability in health informatics research</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F1AC6FE2-39E7-457F-8C26-C8818E44203F</gtr:id><gtr:impact>Presentation as MRC organised conference: Strengthening the UK's capability in health informatics research. Conference was attended by 200+ delegates including, UK Minister, policymakers, research community and industry

Agreement to create the Farr Institute; development of the UK Health Informatics Research Network</gtr:impact><gtr:outcomeId>jrRRPxw9g8J</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hong Kong University - international lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>824F7727-9B68-4E8D-9986-CEBDE928D2C7</gtr:id><gtr:impact>These numerous lectures provided DPUK in depth overview and dementia related discussions.</gtr:impact><gtr:outcomeId>56e9864b050843.72324552</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Informatics and Population Health Sciences. Presentation to MRC Population Health Strategy Board, London - 19/10/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4646041D-F24D-4186-BA5E-E0F98398861E</gtr:id><gtr:impact>Informatics and Population Health Sciences. Presentation to MRC Population Health Strategy Board, London</gtr:impact><gtr:outcomeId>56a5f9dab54854.29981483</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Medical Research Council open meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3BC6942D-7B42-46A8-99D2-439169F76CD5</gtr:id><gtr:impact>Discussion forum with partners in the dementia research field.</gtr:impact><gtr:outcomeId>58c920aa10f966.98064231</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary Speaker at Clinical Trials in Alzheimer's Disease (CTAD) conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE30536B-9681-41AE-95CA-AA1D3DFBF9B1</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5836c3d76a4d91.60857883</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>External talk at the ITMAT workshop on data science challenges and opportunities in Translational Medicine</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>435174CE-E9FD-4694-8BC8-214CDAE063BB</gtr:id><gtr:impact>Talk to influence research on data science challenges.</gtr:impact><gtr:outcomeId>58c919f8155a99.86809734</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Neuropsychiatric Association Annual meeting 24 February - medalist lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8B7D684-F1B5-475B-B9EF-6EB92CDDD3BF</gtr:id><gtr:impact>Discussion of nosological challenges in dementia.</gtr:impact><gtr:outcomeId>58caaed472edc5.32060416</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://bnpa.org.uk/wp-content/uploads/2017/02/BNPA-FINAL-PROGRAMME-2017.pdf</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at Primary Progressive Aphasia: BNPA Annual Meeting, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E463B84D-2D59-4628-8F4A-CB70E6BFF2EB</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c921985e00b6.52569899</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on future Farr UK Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4E7A40D2-F686-4804-821F-44C3B5913BA8</gtr:id><gtr:impact>Presentation on future Farr UK Institute to MRC Population Health Sciences Group, London</gtr:impact><gtr:outcomeId>564c7b87189d20.51523976</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's &amp; Parkinson's Disease Congress 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>144BDBD8-7810-41E2-B39C-4488DB65B54D</gtr:id><gtr:impact>The 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD 2015) will build on the well-earned reputation of previous AD/PD meetings for unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases.</gtr:impact><gtr:outcomeId>56e97bae3a4318.59435851</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/events/?yy=2015&amp;mm=3</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OPDC Open Day 2016</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>312DE26A-FF1C-4D98-A721-3945E6F6E639</gtr:id><gtr:impact>OPDC Open Day 2016
250 OPDC study Participants and Partners registered for event. 
Day of talks from Michele Hu, Fahd Baig, Claudio Ruffmann, Tom Barber and Richard Wade-Martins. 
Discussion of what participants would like from study.
Talks filmed and podcasts added to website</gtr:impact><gtr:outcomeId>5874d331903c21.75233812</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:url>http://www.opdc.ox.ac.uk/openday2016</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Horizon - filming 2015-16</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A559F263-FAAF-47D2-855E-1F7CB08B9F67</gtr:id><gtr:impact>BBC Horizon were interested in making a programme about Alzheimer's disease with a focus on novel technology - especially imaging - for early diagnosis and trials.
Several meetings were held with the produced and his team and then several days of on-site filming including following a research subject.
The film is due to be shown in Spring 2016 as a one hour long programme which is likely to reach an audience of more than a million</gtr:impact><gtr:outcomeId>56e04162cb7c82.67188981</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EPAD consortium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3CE8486B-8EB1-403B-84E5-FF281541E3C7</gtr:id><gtr:impact>Attendance at event to collaborate with partners to share progress in dementia research.</gtr:impact><gtr:outcomeId>58c9235350d214.65015343</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaking re young onset dementia: Royal college of Physicians, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0314EAD3-457D-48F4-8682-3A0EA36B75C1</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c92341363616.69292786</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at International Health Data Linkage Conference, Vancouver</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1AE7CBB1-C49D-4544-B999-E26F40F17BC3</gtr:id><gtr:impact>Presentation title - Using data linkage to support measurement of the Global Burden of Injuries

-</gtr:impact><gtr:outcomeId>543cede6464d14.73067372</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Developments in data sharing technologies at Farr centre in Swansea: UKSeRP and NRDAs. MRC Stratified Medicine consortia, London - 24/11/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF7F5B68-87B6-4ED3-BA5A-57EBD5E02617</gtr:id><gtr:impact>Developments in data sharing technologies at Farr centre in Swansea: UKSeRP and NRDAs. MRC Stratified Medicine consortia, London</gtr:impact><gtr:outcomeId>56a5fb2b2b4e67.94973166</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Population data and modelling: dementia as exemplar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D7523DB5-308E-4F71-AD0F-CC9436F28FD6</gtr:id><gtr:impact>A talk was given at the Cumberland Initiative Festival of Evidence on 5 October 2016.</gtr:impact><gtr:outcomeId>58caad74b6ab81.00837586</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social Media</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0135FD94-5E61-42D7-BEAC-BC2DBDC8EAF9</gtr:id><gtr:impact>The social media presence of Dementias Platform UK is intended to demonstrate the core personality of the project, sharing:
 - Expert voice
 - A network of research excellence
 - Human connection.

DPUK's social media presence is focused on Twitter, though in the future it may also reach LinkedIn.

Social media is used to share updates on the project's work: its research, daily activity, funding awards open, news, and any open recruitments, It also demonstrates its networked and human approach by sharing content from charities, linked researchers and any current human interest news stories. Finally, in the coming months it will strengthen its ability to share its expert voice by facilitating twitter takeovers from key researchers, particularly Early Career Researchers.

DPUK has 1,636 followers - a 173% increase on 2016.</gtr:impact><gtr:outcomeId>56e97ad486d5c5.76366652</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://twitter.com/dementiasuk</gtr:url><gtr:year>2006,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Young Onset and Rare Dementias 2014 event at House of Lords</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4F0D844E-D38D-4473-9CB9-FEF72449831A</gtr:id><gtr:impact>Awareness-raising event regarding young onset and rare dementias
The event was attending by member of parliament and the House of Lords as well as charities, patient families and other organisations</gtr:impact><gtr:outcomeId>56dedbf875e258.04358196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://www.youngdementiauk.org/news/young-onset-awareness-event-house-lords</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Manchester Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>58524219-D726-444C-8E98-93DF7BCB9737</gtr:id><gtr:impact>The Alzheimer's Research UK Conference is the UK's largest dementia research conference and this year Alzheimer's Research UK hope to host up to 450 delegates in the Neo-Gothic surroundings of Manchester Town Hall. With no parallel sessions, this is the perfect conference to gain insight from basic researchers through to clinical colleagues.
Latest insights from basic and clinical research.</gtr:impact><gtr:outcomeId>56e835059f9290.77356543</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/event/alzheimers-research-uk-conference-2016/</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NHS Lothian Annual Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C364C413-CCA3-4D93-9D3D-E6CDBD377783</gtr:id><gtr:impact>Clinical Research : driving efficient, innovative and effective healthcare.</gtr:impact><gtr:outcomeId>58c9601193e686.42366108</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary Speaker at European Academy of Neurology on Imaging Trials and Dementia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ADF16455-46AB-4CCB-BA9B-C95E229A7944</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5836c3977cc4c9.33583071</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary speaker: The neurology of ageing, ABN Annual Meeting, Brighton</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F3E35DE4-C0DE-406B-BF16-AD2D6A9599F5</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c921fd11e0c3.24034165</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at High Performance Computing and Big Data Conference, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30D98E98-8670-40AB-B69B-CEF90B3AB9FF</gtr:id><gtr:impact>Presentation title - Improving health through Big Data

-</gtr:impact><gtr:outcomeId>543ce940d86973.01972154</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Parkinson's UK Branch Richard Wade-Martins</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1A847C00-098E-41B8-AAD9-BC7D0B38A419</gtr:id><gtr:impact>Prof Richard Wade-Martins on the latest projects at the Oxford Centre for Parkinson's Disease Research</gtr:impact><gtr:outcomeId>587515c05182d4.99221332</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural academic conference: Tools for science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8A758411-39C3-4E3F-A510-27FF2F1EBE74</gtr:id><gtr:impact>Inaugural conference for Dementias Platform UK to engage researchers in our academic and industry partner institutions and beyond. Presentations from speakers covering all areas of the Dementia Platform and cohorts encouraged to join the platform. Engagement of early career researchers through a poster presentation competition.

37 posters were exhibited, some with interactive stands, and demonstrated the progress of work delivered through the DPUK Work Programme and Infrastructure Networks.

Dr Carol Routledge discussed the opportunities available through the Dementia Discover Fund and Maria Carrillo, PhD, Chief Science Officer from Chicago gave her first impression of DPUK &amp;quot;The Dementias Platform UK and Alzheimer's Association have a lot of opportunity to collaborate in the future in my view and John Gallacher and his team have also agreed with that, and this is one of the reasons why we have been asked to listen in and help future thinking and brainstorm ideas that might come about with DPUK's established network.&amp;quot;</gtr:impact><gtr:outcomeId>58c92a09bbb3b6.68141217</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/tools-for-science-dpuks-first-annual-conference-in-brief/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Launch of the MRC UK Dementias Platform, Royal Society, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DE1A661F-1D78-4807-8CCB-6BB193A9E6B8</gtr:id><gtr:impact>More than 200 people attended the conference launch. I presented as leader of the Informatics Platform Work Package in the morning and the interactive discussion with industry in the afternoon

a number of contacts were made with industry colleagues with plans for follow up meetings</gtr:impact><gtr:outcomeId>543cf28d163a48.36697447</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/research/facilities/dementias-research-platform-uk/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementias Platform UK (DPUK) Scientific Symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D3B0315D-4F35-49CC-BB2D-42E5B4BED856</gtr:id><gtr:impact>The purpose of the Symposium was for all members of DPUK to come together to discuss and learn more about the scientific activity of the Platform, specifically looking at the main themes of Cohorts, Networks and Experimental Medicine.</gtr:impact><gtr:outcomeId>583d76e386f5b2.35839288</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Clinithink, Swansea - 10/4/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4AF8785D-4891-4642-86AE-7F55A37F98C8</gtr:id><gtr:impact>NLP of Emergency Department data: Early experience. Presentation to Clinithink, Swansea</gtr:impact><gtr:outcomeId>56a5f2cf96c403.15932355</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;The Funny Side of Parkinson's&quot;</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BCF8D6FE-097B-4666-9F06-37FB8CF29342</gtr:id><gtr:impact>&amp;quot;The Funny Side of Parkinson's&amp;quot; on BBC1. Paul Mayhew-Archer Documentary. 
Richard Wade-Martins and Fahd Baig appeared to talk about OPDC.
Paul was named best presenter at the Grierson Awards for this documentary.</gtr:impact><gtr:outcomeId>5874f7f9d695b7.15248029</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/iplayer/episode/b072xkcz/inside-out-south-parkinsons-the-funny-side</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Privacy protecting data linkage for population health. Presentation for Fondazione Lanza, Padua - 2/12/14</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5111C16C-A7C9-4980-A323-E463A054E224</gtr:id><gtr:impact>Privacy protecting data linkage for population health. Presentation for Fondazione Lanza, Padua</gtr:impact><gtr:outcomeId>56a60905584a93.60974115</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK conference 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A460B8BB-EBA2-48D0-9219-7138EB7661B2</gtr:id><gtr:impact>Lots of questions

More interest in taking part in dementia research</gtr:impact><gtr:outcomeId>5647b0469988c0.87828643</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Precision Medicine Catapult - 17/11/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D1414676-4ADE-409C-998A-84A904955A64</gtr:id><gtr:impact>Presentation to Precision Medicine Catapult tem leaders from Cambridge University at visit to Swansea University

Precision Medicine Catapult team asked to come back to discuss opportunities and projects in more detail</gtr:impact><gtr:outcomeId>564c7af2e6fc73.09821325</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Late night event at The Science Museum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D21B3BC5-D876-4EC0-BED8-575DF5969C2E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>583452a3587c32.61385198</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementias Research Platform UK. Presentation to Farr Institute International Advisory Board - 15/12/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D998415A-0826-4001-A73B-AC4772E375EB</gtr:id><gtr:impact>Dementias Research Platform UK. Presentation to Farr Institute International Advisory Board, London</gtr:impact><gtr:outcomeId>56a5fec04b1936.36823912</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Data Linkage to Cohort Studies. Presentation to CLOSER research group, London - 3/11/14</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8D6C9BB5-4750-4FA3-8F32-A28E1E4C5395</gtr:id><gtr:impact>Data Linkage to Cohort Studies. Presentation to CLOSER research group, London</gtr:impact><gtr:outcomeId>56a60834687300.27316441</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at MRC Strategic meeting between health and bioinformatics centres - 29/1/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5040A51D-B729-444D-A5E2-37B2AE5BE3C8</gtr:id><gtr:impact>Centre for Improvement of Population Health through E-records Research (CIPHER). Presentation at MRC Strategic meeting between health and bioinformatics centres, Windsor</gtr:impact><gtr:outcomeId>56a5ed75dc1c15.05220796</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Farr Institute: Distributed multi-disciplinary team science in action. International Population Data Linkage Network Conference - 24/8/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38773939-FA2A-4E4E-AB0C-A902C6FF0BF5</gtr:id><gtr:impact>Farr Institute: Distributed multi-disciplinary team science in action. International Population Data Linkage Network Conference, Swansea</gtr:impact><gtr:outcomeId>584eaba9346098.96348667</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>23/06/15. Privacy protecting data linkage research : a key tool in hastening translation and achieving population impact. Invited presentation McGill University, Montreal</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>962D07D6-DCCE-4294-8D4E-4F888BDD22DF</gtr:id><gtr:impact>23/06/15. Privacy protecting data linkage research : a key tool in hastening translation and achieving population impact. Invited presentation McGill University, Montreal.</gtr:impact><gtr:outcomeId>56b46823c15855.11875376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia: population and public health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6CD7FDFB-825B-4865-B2C4-F784118D6934</gtr:id><gtr:impact>A talk was given for the visit of the DRI director on 19 October 2016 at the University of Cambridge, IPH.</gtr:impact><gtr:outcomeId>58caae0946b9d5.13395688</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview in Civil Service Fast Stream blog - How Stem Cells Can Boost Our Knowledge and Understanding of the Causes of Dementia</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0264F621-6D47-493A-910A-E2EF390871E3</gtr:id><gtr:impact>This is the third and final in a series of interviews carried out by a group of civil servants that have dedicated time to raising money and awareness for dementia via 'The Fund', a Fast Stream initiative. Alison Leishman, Home Office, interviewed Professor Wade-Martins about his research into dementia.
Richard discussed OPDC and the DPUK.</gtr:impact><gtr:outcomeId>587cda797336c8.92618385</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://faststream.blog.gov.uk/2016/05/20/the-fascinating-world-of-research/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mental Health Data Science Meeting (event part-funded by Farr Institute CIPHER)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>706220D3-5D5C-4E33-B36C-5BDBAEFD0DF9</gtr:id><gtr:impact>Assessment of complex interventions using routine data</gtr:impact><gtr:outcomeId>56e02a8ba69238.80339783</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to joint meeting of UKDP, EMIF (European Medical Information Framework) and eTRIKS (European Translational Information and Knowledge Management Services), London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8FC9FF70-1A68-4DA8-AE50-385E6103BEDC</gtr:id><gtr:impact>Presentation title - UK Dementia Platform Informatics

-</gtr:impact><gtr:outcomeId>543cf0dced4e87.16854117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival (in partnership with Alzheimer's Re-search UK)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CED24D9C-7582-4F3F-8548-301173038420</gtr:id><gtr:impact>Sponsored event - How your life affects your brain.
Can the way you live reduce your chance of developing Alzheimer's? By monitoring groups of people over their lifetimes, and with genetic data, brain scans and medi-cal histories researchers are building as complete a pic-ture as possible of how dementia develops. John Gallacher and Nick Fox join us to show how these stud-ies can uncover the risks involved in developing forms of dementia, and how they can be avoided.</gtr:impact><gtr:outcomeId>56e984b64fe081.98732012</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/events/?yy=2015&amp;mm=6</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OPDC YouTube channel</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>81D25506-D327-45D9-A90A-AEE5AC4348DE</gtr:id><gtr:impact>Creation of OPDC YouTube channel to collate our podcasts etc.
32 subscribers, &amp;gt;2,860 views Feb 2016-Jan 2017. 
2016 talks &amp;gt;1,450 views, 
2016 OPDC highlights video &amp;gt;350 views, 
2015 talks &amp;gt;1,000 views</gtr:impact><gtr:outcomeId>587905ed2ba642.19947208</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/channel/UCGzboizARwaAUFW5FjPmmZw</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to the MEPs about DPUK, EPAD and ROADMAP</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A6742C0-A4EB-4852-9560-15800CC0DF69</gtr:id><gtr:impact>Presentation to MEPs about DPUK, EPAD and ROADMAP.</gtr:impact><gtr:outcomeId>58c926dab9c708.72668235</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Informatics, epidemiology and interventions: Network working and coordination of data resources. MRC Neurodevelopmental Disorders Research Network, London - 23/11/15</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>38489397-777D-4A27-8A93-FBC4FD22D5D1</gtr:id><gtr:impact>Informatics, epidemiology and interventions: Network working and coordination of data resources. MRC Neurodevelopmental Disorders Research Network, London
Decision made that a Neurodevelopmental Disorders Research Network would require a data platform similar to the Dementias Research Platform UK</gtr:impact><gtr:outcomeId>56a5fab9585467.58930023</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Society Annual Research Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2FE193F0-5505-4D8A-AA26-332C39081B38</gtr:id><gtr:impact>The Dementias Platform UK: what is it and what can it do for you?

The Alzheimer's Society Annual Research conference will take place on 29-30 June 2015 at the Mercure Manchester Piccadilly Hotel. The conference will bring together researchers and people affected by dementia.</gtr:impact><gtr:outcomeId>56e98530e2f558.75378081</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/events/?yy=2015&amp;mm=6</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Dementia Research Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>94905396-8171-4D7F-A9D4-F04121F80698</gtr:id><gtr:impact>The event showcased the latest developments in memory, dementia and ageing research from cells and animal models to cognitive neuroscience and the clinic.</gtr:impact><gtr:outcomeId>58c92afc5cc1b7.28152103</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.dpag.ox.ac.uk/research/wade-martins-group/oxford-aruk-network-centre/research-day-2015</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rare Dementia Support Group Launch 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CD920C42-B335-4BE7-927F-68762016B8E6</gtr:id><gtr:impact>Rare Dementia Support Fund created with the ambition to increase fundraising and extend the support service further, throughout the UK and beyond.
Extremely well attended</gtr:impact><gtr:outcomeId>56dedb53e93117.65300017</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.nationalbrainappeal.org/rare-dementia-support-launch-event/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Association International Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D70214D0-8CBB-40A0-B79B-EC85CC82E974</gtr:id><gtr:impact>International Conference to highlight progress made and new opportunities in dementia research. AAIC attracts international investigators, clinicians and care providers gather to share the latest study results, theories and discoveries.</gtr:impact><gtr:outcomeId>58c921fd094f11.87757511</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>1946 70th birthday event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0990CEA7-09BA-4FC1-A374-FE47BC087E32</gtr:id><gtr:impact>The 70th Birthday Event celebrated the 70th birthday of participants in the MRC NSHD (1946 birth cohort) - we provided a display of brain imaging</gtr:impact><gtr:outcomeId>56df48d57376c4.38313261</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Society debate: How can we beat dementia in the next twenty years</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB7B8B35-813D-44E5-A087-09552744A561</gtr:id><gtr:impact>Organised by the Alzheimer's Society. this involved patients, carers, supporters and the media who have had subsequent interest in research. very positive feedback from the Alzheimer's Society who were grateful for the input.</gtr:impact><gtr:outcomeId>58bfdc208becf7.04803794</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Co-organised Synaptic Health Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2861ED55-BA5B-4AAD-A8F1-11D31473B39E</gtr:id><gtr:impact>A 2 day workshop for the Synaptic Health experimental medicine work package. Attendees were academics and industry scientists involved in the workpackage or who are interested in collaborating. Outcomes were decision to write a number of collaborative research proposals to obtain research funding.</gtr:impact><gtr:outcomeId>58c7c2e65a4d17.57605355</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaking re fluid biomarkers in AD. Educational Workshop. AAIC, Toronto</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>03A3D812-33E8-43E7-ABF4-90CEB8B83A58</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c922cead35a1.74150966</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Janssen Symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A904408-F7E2-4C90-ACFD-AC1494FBCBA5</gtr:id><gtr:impact>Discussion and collaboration with industry partners.</gtr:impact><gtr:outcomeId>58c921348e27b8.95116609</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Insight 46 launch facebook offices</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FE9A0E0F-D749-49E1-A1CE-65EDA18357AB</gtr:id><gtr:impact>Talk sparked questions and included George Freeman MP - Minister for Life Sciences

A number of members of the audience asked for further information</gtr:impact><gtr:outcomeId>5647af86862d81.79552089</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94E02E0B-1E1F-44C6-9248-2E18BAE1FEDD</gtr:id><gtr:impact>Talk led to a lot of questions and discussion - for almost an hour after the event

A number of people expressed interest in taking part in research</gtr:impact><gtr:outcomeId>5648c804c46907.04699825</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/event/cheltenham-science-festival/</gtr:url><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at launch of UK Dementia Platform</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>011B6A92-ECF4-49EF-833D-BD771BEF0559</gtr:id><gtr:impact>Oxford plays a significant role in the partnership and Oxford Neuroscience researchers lead a number of projects. This was reflected in the scientific programme of launch day. Simon Lovestone (Psychiatry) gave a talk on the NIHR-MRC Dementia Deep and Frequent Phenotyping Feasibility Study while Richard Wade-Martins (DPAG) spoke on the UK Stem Cell Network.

Coverage in the media</gtr:impact><gtr:outcomeId>54b917a8343d87.24005440</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multi-sectoral data linkage for intervention and policy evaluation. Invited presentation to 7th ESRC Research Methods Festival: advancing social science research methods - 6/7/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3A8D549-F56D-4062-A41C-C82EDDFA8F3B</gtr:id><gtr:impact>Multi-sectoral data linkage for intervention and policy evaluation. Invited presentation to 7th ESRC Research Methods Festival: advancing social science research methods, Bath</gtr:impact><gtr:outcomeId>584ea8f0a5ba95.58634845</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British  NeuroPsychiatric Association Annual meeting 24th February - medalist Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>30AAFFD5-9C5F-4D4A-AAC1-72E044254CA0</gtr:id><gtr:impact>Discussion of nosological challanges in Dementia</gtr:impact><gtr:outcomeId>58a70ce00fc015.68446119</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://bnpa.org.uk/wp-content/uploads/2017/02/BNPA-FINAL-PROGRAMME-2017.pdf</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Competent Authorities for Medical Devices Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9F1C8BDA-5B2D-4F91-A195-122FC3172658</gtr:id><gtr:impact>Discussion to influence policy and practice relating to medical devices.</gtr:impact><gtr:outcomeId>58c9203de5bd52.40865870</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A population perspective on dementia and its relationship with ageing and dying across time</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B16433CB-AEE4-4E70-A8CA-4AD8E2F80035</gtr:id><gtr:impact>Invited speaker at Brocher foundation, Geneva, 14-15 April 2016. The redefinition of Alzheimer's disease and its social and ethical consequences.</gtr:impact><gtr:outcomeId>58caac1b610fc3.31698473</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medicine and Me:  Living well with Dementia</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>600FE260-CBCB-4211-9EE5-CEDF8FE02823</gtr:id><gtr:impact>Giving a talk on types and diagnosis of dementia at this half day meeting.

The Medicine and Me series of meetings at the RSM aim to update on important conditions and gives a direct voice to patients and their carers to air their concerns on the impact of diagnosis, investigation and management. Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts by our patients to improve care.
The audience at this meeting will comprise of those living with dementia, their families, carers and advocates, representing about 70% of those present; and clinicians and researchers, representing not more than 30%. Clinicians will include doctors, specialist nurses and others involved in the treatment and care of those who have this condition</gtr:impact><gtr:outcomeId>56e12b3ccd1859.38038793</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.rsm.ac.uk/events/events-listing/2015-2016/groups/public-engagement-programme/mmg01-medicine-and-me-living-well-with-dementia.aspx</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Data science: solving the grand challenge of interdisciplinary working for UK biomedical, clinical and epidemiological sciences.  Invited presentation at UK Roadmap for Biomedical Metabolic Phenotyping retreat, Wellcome Genome Campus, Hinxton - 11/10/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>41EBE115-C71F-4697-AF0E-0874FA9BB79D</gtr:id><gtr:impact>Data science: solving the grand challenge of interdisciplinary working for UK biomedical, clinical and epidemiological sciences. Invited presentation at UK Roadmap for Biomedical Metabolic Phenotyping retreat, Wellcome Genome Campus, Hinxton</gtr:impact><gtr:outcomeId>584ead58856084.77973112</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaking at EAN, Copenhagen, Focal dementias, Convener, lecturer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>98F26F43-8C0F-447E-9131-EFC44774CE5D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c9227f50da96.47637986</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation with Mick Dennis (Swansea) and Daniel Davies (UCL) to UK Biobank/DPUK neorodegerative outcomes group - 6/1/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5F086B01-3413-4D62-ACEF-D4FD16A8DC27</gtr:id><gtr:impact>Research Proposal: Dementia and Cognitive Impairment identification in routine health data: development and validation of algorithms within SAIL using CFAS cases.</gtr:impact><gtr:outcomeId>56a5ed2541f634.05422077</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK scientific meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF0A7526-1FF0-4E1E-A699-D285271E9F97</gtr:id><gtr:impact>Awareness raising for DPUK and building networks.</gtr:impact><gtr:outcomeId>58c930af77c887.03497017</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School of Medicine 'Science in Health' Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F7244B69-0AFD-43A8-8827-AC18F45283F1</gtr:id><gtr:impact>Professor John Gallagher spoke at a Cardiff University public medical lecture and the aim of these lectures is to open up areas of concern in health care, and second, to inform the public about current medical research.</gtr:impact><gtr:outcomeId>56e8336288ce55.19646453</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/event/school-of-medicine-science-in-health-public-lecture/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to UK Biobank and Oxford Big Data Institute, Swansea</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA93C715-DCD3-44B8-A649-27DC7BD5BF0A</gtr:id><gtr:impact>Presentation title - Use of UK Secure e-Research Platform (UKSeRP)

-</gtr:impact><gtr:outcomeId>543cf12df30ba6.07956781</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Transforming UK Biomedical and Health Informatics. Lecture to MSc in Health Data Analytics students, Swansea - 26/10/15</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0503FD0E-BB06-4700-871E-9E831C0906A6</gtr:id><gtr:impact>Transforming UK Biomedical and Health Informatics. Lecture to MSc in Health Data Analytics students, Swansea</gtr:impact><gtr:outcomeId>56a5fa2a415764.34520018</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5-7 October 2016, CCNA ISAB (Vancouver)(premanifest disease &amp; cognitive footprint?)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8B117A97-98F5-400E-B1CA-9F1F2ED28231</gtr:id><gtr:impact>Plenary lecture at Canadian consortium on Neurodegeneration and aging</gtr:impact><gtr:outcomeId>58a6f9b787d4a9.14407737</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Secure Anonymised Information Linkage (SAIL) system. Educational presentation to the Confidentiality Advisory Group, Health Research Authority - 7/9/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE4DEA5D-2BB5-4166-BDF2-72FD272C81D0</gtr:id><gtr:impact>Secure Anonymised Information Linkage (SAIL) system. Educational presentation to the Confidentiality Advisory Group, Health Research Authority, London</gtr:impact><gtr:outcomeId>584eabde0cba77.34287239</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia and a Research Institute - Interview in the Sun Newspaper 5Oct15</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A50B78DD-34B9-4C73-8B48-495FCCA36824</gtr:id><gtr:impact>Publicity to promote the fact that 5p from each carrier bag bought would be donated to the Dementia Research Centre. This was the brainchild of Malcolm Walker (Iceland) with Nick Fox (DRC)</gtr:impact><gtr:outcomeId>56dee3118a7217.82945117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.thesun.co.uk/sol/homepage/woman/health/health/6735025/5p-bags-could-help-combat-dementia.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaking Cambridge Dementia Course: MRI in dementia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB569E16-7E52-4851-966C-E30247A52F00</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c92308362ca1.09445540</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Melodem progress meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>16D2825A-33AB-4384-9636-7AEA632C65A3</gtr:id><gtr:impact>Participation in a progress meeting for dementia researchers.</gtr:impact><gtr:outcomeId>58c922cf94c812.45386077</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/wp-content/uploads/2016/06/Agenda_Melodem_30June-and-1-july-2016_v1.0.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 26 April 2016, DPUK Annual Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A3B059AD-8A87-4419-B430-32F50CF8231A</gtr:id><gtr:impact>DPUK Open Day</gtr:impact><gtr:outcomeId>58a703a89d64f1.36061489</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/wp-content/uploads/2016/06/Conference-Programme.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Medical Information Framework</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D856F8F9-43E9-4EC0-AE29-348A0D259E55</gtr:id><gtr:impact>More than 75 EMIF team members gathered in Budapest March 14-16, 2016 to not only share status updates on the ongoing work, but also discuss new joint AD/Metabolic scientific questions to be addressed using the EMIF framework.

Overall, tremendous progress was shown for both research projects, with many more exciting results being underway and opportunities for further collaboration identified. In particular the overlap between AD and metabolic disorders, due to inflammation, such as in Diabetes Mellitus Type 2, has provided opportunities for shared work.</gtr:impact><gtr:outcomeId>58c9241d2a8881.59206653</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.emif.eu/news?news_news=5</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Medical Information Framework conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>84392E7A-92A0-42DE-B058-5BA91E2A6851</gtr:id><gtr:impact>Research conference to demonstrate use of new tools and methods for the dementias research community.</gtr:impact><gtr:outcomeId>58c91e6f5c1983.34804513</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.emif.eu/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cecilia (Heyne) Lee Pint of Science Public Engagement Talk, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>283B58D4-EBAB-4BD4-AAE0-9CE05A9B1104</gtr:id><gtr:impact>Pint of Science Public Engagement Talk, Oxford, Autumn 2016 on using iPSC for modelling neurodegeneration</gtr:impact><gtr:outcomeId>58c9610f00c1b1.70240513</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interviews on Parkinson's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ADB83442-195D-4E60-9754-5B02B926E1FB</gtr:id><gtr:impact>Radio interview to raise awareness and Parkinson's fund raising sponsored event

Raised awareness and money</gtr:impact><gtr:outcomeId>569826e65b1605.07539074</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MS Society Public Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>17D836AB-8B53-4460-85CF-2FE4EA727DB5</gtr:id><gtr:impact>A presentation to members of the MS Society</gtr:impact><gtr:outcomeId>58c960659d2bc4.84977327</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Generation Scotland Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3C63783-44D7-49E7-8679-A0EA6889A5C0</gtr:id><gtr:impact>Awareness raising for DPUK and building networks.</gtr:impact><gtr:outcomeId>58c9314d738347.96123655</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on Health / Bioinformatics at Swansea University.  Visit of Prof Julie Williams, Chief Scientific Advisor for Wales</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EE6FC99E-634C-48B8-873C-8229C6F92D57</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>543cd9faefcfe2.68359952</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DPUK Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0E4CD41-1117-4EA9-BA04-04258BF00E4B</gtr:id><gtr:impact>The DPUK newsletter is issued three times a year.

It regularly includes updates from the Director, notifications of the conference and other events, news on project successes, and information on collaborative activity and any awards available.

Through the newsletter, there is increased engagement from the project's target audiences with DPUK's work and events.</gtr:impact><gtr:outcomeId>56e831fcedfc19.03692500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/info-support/newsletters-and-reports/</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DPUK Stakeholders Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0B479991-3B5C-4CED-AB5F-3215EDBB5888</gtr:id><gtr:impact>Raised awareness of use of stem cells in dementia research</gtr:impact><gtr:outcomeId>56ddfa03c60f42.77600773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Many Faces of Dementia - massive open online course (MOOC)</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C5270A0E-2212-41E8-9652-A4B142B075FE</gtr:id><gtr:impact>I was interviewed for an online course about the rarer forms of dementia, my interview related to the clinical features of frontotemporal dementia. I also performed the voice over and welcome to the course that appeared in the course trailer video. The course, due to start March 14th 2016 is a 'massive open online course' available at www.futurelearn.com/courses/faces-of-dementia. Over 12,000 people have registered for the course (as of 8th March 2016).</gtr:impact><gtr:outcomeId>56dee25b908d37.28200715</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.futurelearn.com/courses/faces-of-dementia</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Association International Conference (AAIC)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8008ECB-DE89-4B7F-8D3A-3425E9C40E96</gtr:id><gtr:impact>Present research at AAIC, which is the largest international meeting dedicated to advancing dementia science. The purpose is to disseminate our research and to learn about current and novel research in dementia science.</gtr:impact><gtr:outcomeId>583d74f9525cf5.94657491</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementias Platform UK (DPUK) scientific symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6C3F2193-E5F4-456F-92C1-411EC17A4E71</gtr:id><gtr:impact>The purpose of this symposium was for all members of DPUK to come together to discuss and learn more about the scientific activity of the Platform, specifically look at the main themes of Cohorts, Networks and Experimental Medicine</gtr:impact><gtr:outcomeId>58b6b81c743bb0.94220216</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Alzheimer's Disease Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>75317369-08A4-4C0B-8AD1-90092C726E35</gtr:id><gtr:impact>Participation in international conference. This was an opportunity to share progress and updates in dementia research infrastructure with Alzheimer's Disease Research Network, SRT Ageing, &amp;amp; Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong Co-organized this with the Faculty of Architecture, Faculty of Social Sciences, Sau Po Centre on Ageing &amp;amp; SRT Science of Learning, The University of Hong Kong, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Shenzhen University (College of Life Sciences), Hong Kong Science &amp;amp; Technology Parks Corporation, &amp;amp; The Hong Kong Society of Aging Research.</gtr:impact><gtr:outcomeId>58c9261b0680b3.89129971</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meetings with Insight46 donors via ARUK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>804D3E96-EF47-40B6-A9FD-4EB2A4BCA042</gtr:id><gtr:impact>Meeting with Insight46 donors via ARUK to discuss Insight46 and dementia research.</gtr:impact><gtr:outcomeId>583d790236da80.06378492</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ethical Risk Assessment in Biomedical Big Data - Protecting privacy through design</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2EDB735E-C143-4180-9C50-735E244EACB4</gtr:id><gtr:impact>Protecting privacy through design</gtr:impact><gtr:outcomeId>56e02ac04d22b7.04481030</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DPUK Annual Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>349EFCFB-4BBE-4952-9DFA-CCE778425FF0</gtr:id><gtr:impact>DPUK's annual scientific conference 2017 is open to researchers, funders, government, charities and the public. The keynote speaker will be Monique Breteler. The focus of the day will be on demonstrating tools, presenting data on outcomes to date, and showcasing the complementarity of the Dementia Resource Institute and Dementias Platform UK.

This will be the fourth DPUK conference.</gtr:impact><gtr:outcomeId>56e8314e6060d3.11389582</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/event/dementias-platform-uk-annual-conference-2016/</gtr:url><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC One Saturday Breakfast News - Funny Side of Parkinson's</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E401967-C7B9-47A2-9C2E-914333818C4F</gtr:id><gtr:impact>Richard Wade-Martins appeared on BBC One Saturday Breakfast News with Paul Mayhew-Archer to discuss our research using stem cell technology to grow and study dopamine neurons from skin cells.</gtr:impact><gtr:outcomeId>5874f85a126b02.01801115</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-35734888</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>6-7 April 2016, DZNE (Bonn)&quot;The role of genetic cohorts in bridging clinical and basic science&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1F0D981F-5C9A-47EA-8CD8-792A74DD1968</gtr:id><gtr:impact>Discussion of the role of Genetic cohorts to advise the German Neurodegenerative disease research network</gtr:impact><gtr:outcomeId>58a70705d261f3.47753497</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on research at Farr Institute CIPHER to Rebecca Endean - 26/1/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2229FDAF-ED3D-4ACB-9E48-C8146F274422</gtr:id><gtr:impact>Presentation on research at Farr Institute CIPHER to Rebecca Endean, Director Research Base, Business and Science</gtr:impact><gtr:outcomeId>56a5ebcc58df79.24590831</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>November 2016, WISH Summit (Qatar)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>793CEE48-6C4B-4245-8291-9B8D0AC653D4</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>58a6f7d9def5e4.91914072</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Q&amp;A session at Rare Dementia Support Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>02A17AD3-C3B0-47ED-AD7F-1C7A2BD835FE</gtr:id><gtr:impact>Question and Answer session from patients and carers with a diagnosis of frontotemporal dementia</gtr:impact><gtr:outcomeId>58bfca73456db4.23215383</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Innovation Summit for Health (WISH) forum (February 2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7C5939A1-6B80-4D51-8504-AFD7153B7815</gtr:id><gtr:impact>Participated as a panel member looking at issues of dementia funding and research, and how to better inform the public. A report was subsequently published based on the Summit meeting.</gtr:impact><gtr:outcomeId>58caaf7d58da26.32860695</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.nhsq.info/app/media/4053</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Twitter account for OPDC</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>39D2272B-A837-45C6-89D0-ACAD4F477A13</gtr:id><gtr:impact>Active twitter feed for OPDC engages with other research groups and industry. 
Promotes our research, events, news and drives for study participants as well as highlighting relevant news items. 
420 followers, average Impressions 7.8k per month</gtr:impact><gtr:outcomeId>58790454c33345.61743992</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://twitter.com/OxfordPDCentre</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A moving target? Dementia in changing older populations (and a changing world)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C62F543F-4822-4D83-BAD7-663ADD8BF128</gtr:id><gtr:impact>A talk was given at AAIC 2016 (Alzheimer's Association International Conference) 23-28 July in Toronto, Canada.</gtr:impact><gtr:outcomeId>58caac9665d876.06245621</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Data Linkage: an essential tool for efficient observational and interventional research and service delivery. Keynote address at Public Health Science Conference, Cardiff - 27/11/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B45C061-4EAD-4993-8D05-D1037E097C7C</gtr:id><gtr:impact>Data Linkage: an essential tool for efficient observational and interventional research and service delivery. Keynote address at Public Health Science Conference, Cardiff</gtr:impact><gtr:outcomeId>584eaf0a14bd03.25334307</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sanofi/Genzyme: Modulating GBA activity as a Parkinson's disease therapy</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Genzyme Therapeutics Ltd</gtr:fundingOrg><gtr:id>1613A028-1D7C-478A-881E-BE7C3E2FBFDD</gtr:id><gtr:outcomeId>5889c78c2cebf6.35939624</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60852</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Drake Foundation: Head Injury, cognition and imaging correlates of dementia in the Insight 46 cohort</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>EC1912DC-79F9-4C67-9DB9-7081BC3F0B3E</gtr:id><gtr:outcomeId>58c929106fc2b4.27743938</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alcohol misuse: electronic longitudinal alcohol study in communities</gtr:description><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>C79D23B1-ABA3-481A-9051-E123C58ADF39</gtr:id><gtr:outcomeId>545776e3753a32.30582130</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Deep and Frequent Phenotyping Grant (Simon Lovestone PI, awarded 2016)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6D7ACD2E-41A5-46EC-9523-84566E91E0FD</gtr:id><gtr:outcomeId>58ca734bf1d832.43278390</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219355</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Brain Research Trust</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Brain Research Trust (BRT)</gtr:fundingOrg><gtr:id>43717035-0686-442A-9FB7-4016A8F56071</gtr:id><gtr:outcomeId>58b6b90e3f80b9.12453132</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1824093</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>1946 ARUK</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>B15BB4E3-A78E-4F44-AB9B-393E4C81E3DC</gtr:id><gtr:outcomeId>58c92aaf22e172.56143442</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60852</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Drake Foundation: Effects of head injury the NSHD 1946 birth cohort.</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>279A0F2D-3904-4EE8-A017-448C884947F9</gtr:id><gtr:outcomeId>58bfc9c7651032.87324700</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Additional funding from Janssen for Synaptic Plasticity work</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>68935763-4F15-47BD-A2A0-D5F5C7E3C35A</gtr:id><gtr:outcomeId>58c96cdabfb515.56894171</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU IMI-2. Amyloid imaging to prevent Alzheimer's disease (AMYPAD)</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>European Social Survey: European Research Infrastructure Consortium (ESS ERIC)</gtr:fundingOrg><gtr:id>0D2BD999-BC4C-4786-BF40-58F3DDA7D7D4</gtr:id><gtr:outcomeId>58c92bfe31e850.92067327</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Momentum Award (Microglial interactions in Alzheimer's Disease)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6484C633-295C-4F2A-BEF4-7C583704818A</gtr:id><gtr:outcomeId>587e45a28dc6e8.92194268</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Momentum Award (Microglial interactions in Alzheimer's Disease-informatics)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B2EED5BF-7E73-419C-8256-F0B9CA575B37</gtr:id><gtr:outcomeId>588629f79c1719.97126174</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200873</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The development of digital biomarkers for dementia</gtr:description><gtr:end>2022-11-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>A9A81F14-3220-4601-9FE8-A888E8799D2A</gtr:id><gtr:outcomeId>58ca96af818bf2.76436855</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Alzheimer's Research UK Oxford Drug Discovery Institute</gtr:department><gtr:description>ARUK ODDI collaboration: Phenotypic drug discovery in Parkinson's</gtr:description><gtr:end>2020-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>44EDD1D5-E47D-4B11-9769-2D09FE8F8749</gtr:id><gtr:outcomeId>588b4c9b768230.31096654</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>ROADS IMI2 call 6</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0C30C155-D383-44EA-89D4-8C6FB4DE7DD4</gtr:id><gtr:outcomeId>56e19835285390.80287356</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>JPND</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D8971ACB-E96F-44C5-BA2C-5A7327F7C2D1</gtr:id><gtr:outcomeId>569823b6591013.10174032</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>330000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>MJ Fox Therapeutic Pipeline Program: Enhancing autophagy flux in Parkinson's disease</gtr:description><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>2A634900-E1DC-4516-8868-B9C9E73F9FC3</gtr:id><gtr:outcomeId>5889c6a1645bb2.54916321</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>174791</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Trust Clinical Training Fellowship</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>98D551EF-97C3-49DA-B786-9232C70FEAE0</gtr:id><gtr:outcomeId>58b6b96447f316.43274928</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>249965</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving prevention trials in AD through imaging</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:fundingRef>261 (AS-PG-15-025)</gtr:fundingRef><gtr:id>30BADB2D-0A1D-4FB8-BCB6-B8B2E1775669</gtr:id><gtr:outcomeId>56dec395b938a6.72797824</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Partnership Award (Dementias Platform UK Stem Cell Partnership)</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5F755E45-CD61-4134-9E3E-251E00417872</gtr:id><gtr:outcomeId>588626c43ce8a5.39572549</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Vice Chair and Chair Elect, Advisory Council US Alzheimer's Association ISTAART</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>CD5F46C6-6686-4411-A124-CF77A3C9B004</gtr:id><gtr:outcomeId>58c7e0d9510eb5.92220921</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ABN clinical research and academic committee, London representative</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>412E9D1D-FF91-4573-A817-4A2F85AE01B5</gtr:id><gtr:outcomeId>58c927098971f0.18805143</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, Biobank access committee, Brains for Dementia Research</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>637E8413-AC61-424A-AA03-D5E49C6BC221</gtr:id><gtr:outcomeId>58c926ac639a64.65849085</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Deputy Chair, ABN Cognitive Disorders Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B6BCE2E-FB21-4DD7-9511-04C1D333FD4F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c9243e4cc829.24771523</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Press conference</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9FD998B8-D3DD-4C2E-BAE0-F87523743F84</gtr:id><gtr:outcomeId>58bfcaf407cf51.48783279</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Alzheimer Association Educational Workshop: The basics of fluid biomarkers in AD - speaker</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>822F7DA9-2096-4CC5-8C65-0D0DEB092A55</gtr:id><gtr:outcomeId>58c925f643f3a9.87764141</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK representative - European Academy of Neurology Dementia Panel</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>31BF6BEC-CFD9-45C8-98E0-AC1848879FBA</gtr:id><gtr:outcomeId>58c9259eabec53.12406857</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UCL ageing event - cultivating research connections across the university: organising committee and plenary speaker</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>204589D1-9F9E-42BC-81A4-0F199C04F0E7</gtr:id><gtr:outcomeId>58c926612de686.34406790</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Prime Minister's Research Champions Group attending G7/G8 summit</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>151BA41C-EA12-4B91-BBC7-C2BFEF31EC0D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>583c00c76f41e1.78532767</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisor WHO (World Health Organisation)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3AE9B102-5537-4CCD-B77C-3140ECC66974</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>583c01e15a9ba3.54410654</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PCA criteria 2013-2015</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3E0B4AB4-1A4B-408A-9AE7-1B0FF4490E87</gtr:id><gtr:outcomeId>56e04b7c10cba2.49226150</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.alzforum.org/news/conference-coverage/researchers-join-draw-posterior-cortical-atrophy-out-shadows</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>collection of &amp;gt;30 UK cohorts available for cross-cohort analyses</gtr:description><gtr:id>CF78F7A8-0026-4790-BBE0-B2E92275C466</gtr:id><gtr:impact>The bringing together of data from &amp;gt;30 cohorts is transformative in delivering greater data access to the research community</gtr:impact><gtr:outcomeId>56e19a15a69e47.68310338</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DPUK cohorts database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.dementiasplatform.uk/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This model used data from the powerful dataset comprising 17 008 cases and 37 154 controls obtained from the International Genomics of Alzheimer's Project (IGAP). Alzheimer's disease (AD) Polygenic risk scores were generated for 3177 cases and 7277 controls (GERAD data) and tested whether the alleles identified to associate with disease in IGAP sample are significantly enriched in the cases relative to the controls in the GERAD sample. The disease prediction accuracy was investigated in a sample of 3049 cases and 1554 controls (for whom APOE genotype data was available) by means of sensitivity, specificity, area under the receiver operating characteristic curve (AUC) and positive and negative predictive values. The best prediction accuracy AUC = 78.2% (95% confidence interval 77-80%) was achieved by a logistic regression model with APOE, the polygenic score, sex and age as predictors.</gtr:description><gtr:id>253D06BA-DEB5-4539-A90B-3AE19BFD7746</gtr:id><gtr:impact>This approach is used to create SNP arrays for AD prediction (for research only so far).</gtr:impact><gtr:outcomeId>58c6c052a78d75.88851434</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Alzhemer's Disease Polygenic Risk Profiling</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>To enable the detection of a-syn oligomers in stem cell-derived dopamine neurons</gtr:description><gtr:id>97CBE43E-C866-42F5-A3A7-77F0638F3670</gtr:id><gtr:impact>The detection of a-syn oligomers in stem cell-derived dopamine neurons</gtr:impact><gtr:outcomeId>58c92f226e65b1.71774930</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PLA in stem cell neurons</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DPUK has developed a cognitive test battery suitable for use in large-scale population studies.</gtr:description><gtr:id>24C740F5-417D-421D-A107-E365B8A8C66E</gtr:id><gtr:impact>The battery has been deployed in the UK Biobank study</gtr:impact><gtr:outcomeId>58c97092a4dd87.66716841</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cognitive test battery implemented in UK Biobank</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of stem cell-derived neuronal culture techniques using microfluidic devices to channel axonal growth.</gtr:description><gtr:id>AFFD7BFF-C003-4AC9-B5FC-4EC9CAAF5115</gtr:id><gtr:impact>Not yet: it is ongoing development</gtr:impact><gtr:outcomeId>58c92fc5c46df9.80731551</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Dopamine neuron microfluidics</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The DPUK stem cell network has been awarded a MRC partnership grant to establish network activity including the development of standard protocols for developing specific tissue types relevant to dementia research.</gtr:description><gtr:id>8405A27F-4D35-4218-9051-D9BBE32D172D</gtr:id><gtr:impact>TO BE CONFIRMED</gtr:impact><gtr:outcomeId>58c97109e638e4.49842824</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stem cell network protocols</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The DPUK molecular and structural imaging network has been awarded a MRC partnership grant and an ARUK project grant t develop standardised image acquisition and pre-processing protocols for brain imaging.</gtr:description><gtr:id>31272763-5A55-487C-AD81-08CC8FE8B5D7</gtr:id><gtr:impact>TO BE CONFIRMED</gtr:impact><gtr:outcomeId>58c970d2e967f7.58464892</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Imaging network protocols</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have optimised a live cell imaging protocol for the visualisation and measurement of mitochondrial membrane potential in differentiated neurons.</gtr:description><gtr:id>18A86E9A-4355-4A98-A214-5DE31DFB4608</gtr:id><gtr:impact>The membrane potential-sensing dye TMRM can be used to quantify membrane potential, with increased fluorescence indicating increased membrane potential.</gtr:impact><gtr:outcomeId>54b6841230ab09.24845663</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Live cell imaging techniques in iPS-derived DA neurons in vitro</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The ability to perform detailed high-throughput analysis of neurons in culture</gtr:description><gtr:id>28261729-D869-42D9-AA63-26F17026FBC5</gtr:id><gtr:impact>Shared use of best practice in high-throughput analysis using Opera Phenix imager and high-throughout plate readers</gtr:impact><gtr:outcomeId>58c95ca5d1abd9.76246486</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High content, high throughput analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Develop target discovery assays using high throughput screens</gtr:description><gtr:id>D33F8DA6-EDC3-4675-ACB3-686A6ABF44BD</gtr:id><gtr:impact>New research facilty built for our work</gtr:impact><gtr:outcomeId>56982792ce7a02.54150149</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Target discovery assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have been able to establish CRISPR/Cas9 gene editing in our lab as a result of this project</gtr:description><gtr:id>DF7B585C-0F15-4EFF-A27E-87FA0C7ED975</gtr:id><gtr:impact>We have been able to perform gene editing in iPSC lines.</gtr:impact><gtr:outcomeId>56f5c6f30416c1.81461696</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CRISPR gene editing</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The DPUK secure data analysis platform for dementia research brings together over 30 UK cohorts (n=2M) for data sharing. This is a step-change in UK data sharing capacity</gtr:description><gtr:id>8849D0FA-6596-4FA3-B28F-5F18AEF17B75</gtr:id><gtr:impact>By bringing the researcher to the data , the DPUK data portal reduces the transaction costs of data sharing at many levels.
The concept has proven attractive to researchers form France, Netherlands, China, Japan, South Korea, Canada and the US and discussions are underway with these colleague to include their data within the portal.</gtr:impact><gtr:outcomeId>56e1995e78d148.39609342</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>DPUK data portal</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.dementiasplatform.uk/</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of methods for analysis of RNA-Seq</gtr:description><gtr:id>E6906C5D-46DF-43DF-BF51-5E376BBA432F</gtr:id><gtr:impact>Understanding of gene expression profiles in selected cell population</gtr:impact><gtr:outcomeId>569827dfdbc628.53354041</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNA-Seq</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Patch-clamp techniques to measure neuronal activity of stem cell-derived neurons</gtr:description><gtr:id>A093C63F-0797-4E68-9888-B72304BE1390</gtr:id><gtr:impact>Analaysis of stem cell-derived neurons: dopamine neurons, cortical neurons, motor neurons and medium spiny neurons</gtr:impact><gtr:outcomeId>58c95d2d7ddce7.65513659</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In vitro electrophysiology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The ability to generate microglia from human stem cells from dementia patients</gtr:description><gtr:id>207728E3-2699-4067-B96C-2FF34E1EE7A3</gtr:id><gtr:impact>We will be able to compare the function of microglia generated from patients and from controls</gtr:impact><gtr:outcomeId>58c95c059b0260.47839763</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Microglia differentiation</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>UKSeRP is a secure data management and analysis platform created through MRC's capital investment in the Farr Institute. It is an integrated suite of hardware and software tools that enables uses to upload and remotely manage their data and make the data available for analysis to distributed research teams. UKSeRP instances have been created for the MRC Dementias Platform UK, UK Biobank outcome adjudication group, ALSPAC, linked Millennium Cohort Data and the Multiple Sclerosis Register.</gtr:description><gtr:id>1A56C68D-F76F-4F72-B567-DDFD8CE84008</gtr:id><gtr:impact>UKSeRP supports the development and implementation of distributed multi-disciplinary UK Team Science in providing access to multi-modal multi-cohort data.</gtr:impact><gtr:outcomeId>58c6d4d861f9d9.60580149</gtr:outcomeId><gtr:title>UKSeRP (UK Secure eResearch Platform)</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>This collaboration aims to produce smartphone and wearable focused, remote, digital biomarkers targeted at the earliest possible preclinical signs of the disease.</gtr:description><gtr:id>546A40D1-35FE-448F-9758-9C64072CE7BE</gtr:id><gtr:impact>The first of the outputs from this research collaboration are currently deployed in the PREVENT and DFP trials.</gtr:impact><gtr:outcomeId>58ca6bf7bd7666.23709986</gtr:outcomeId><gtr:title>Digital Biomarkers for Dementia</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>933E3ED5-B6F9-460A-8DA6-BE13C44BFEF7</gtr:id><gtr:title>PET Tau and Amyloid-? Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d7a3dfce1ed86e41dbe1293fd3cc46"><gtr:id>28d7a3dfce1ed86e41dbe1293fd3cc46</gtr:id><gtr:otherNames>Koychev I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5a71bb7a8b1715.29188654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBBF6956-5AF4-4B70-8E79-B4ADB1F73CFF</gtr:id><gtr:title>Evaluation of cumulative cognitive deficits from electroconvulsive therapy.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/368eea7a61a58c461f6a93094ad88100"><gtr:id>368eea7a61a58c461f6a93094ad88100</gtr:id><gtr:otherNames>Kirov GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>5a7dcd68309061.92576625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>231BE1C8-BB11-4AC3-8322-A51F5BFBD0E5</gtr:id><gtr:title>Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e17a218daa77aa27ae185d2c0fbbe085"><gtr:id>e17a218daa77aa27ae185d2c0fbbe085</gtr:id><gtr:otherNames>Weston PSJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a6ae63d1170a3.30485562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB0CD0F8-BAC9-47CA-BF33-0567AED1C7D7</gtr:id><gtr:title>Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/150e9e10e3ebe78c54e55b675bce02c7"><gtr:id>150e9e10e3ebe78c54e55b675bce02c7</gtr:id><gtr:otherNames>McLaughlin RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a7dcba7eacb57.61421471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34629CB4-2F89-42B4-85DD-B314DC508732</gtr:id><gtr:title>Prospective associations between adolescent mental health problems and positive mental wellbeing in early old age.</gtr:title><gtr:parentPublicationTitle>Child and adolescent psychiatry and mental health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/657a517be8ab6fd3040d5bdb9fedead5"><gtr:id>657a517be8ab6fd3040d5bdb9fedead5</gtr:id><gtr:otherNames>Nishida A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1753-2000</gtr:issn><gtr:outcomeId>58ca6c8d740391.33479298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F08E55ED-24A1-48D2-983F-4D17077BADBD</gtr:id><gtr:title>Intracranial pulsatility in patients with cerebral small vessel disease: a systematic review.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd91fa878c05d52bd7c1e3a21e702619"><gtr:id>fd91fa878c05d52bd7c1e3a21e702619</gtr:id><gtr:otherNames>Shi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>5aa16581964433.71790856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B64211F9-0DC7-4AEA-BCBC-8A03DAA128FE</gtr:id><gtr:title>Verbal memory and search speed in early midlife are associated with mortality over 25 years' follow-up, independently of health status and early life factors: a British birth cohort study.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c8c78ef79a6c5af275104b65fc05b3d"><gtr:id>2c8c78ef79a6c5af275104b65fc05b3d</gtr:id><gtr:otherNames>Davis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>58ca6c8c87c6f1.74566470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA6D1277-A17F-4289-82B1-5FC0D3FD609D</gtr:id><gtr:title>Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic review.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12b2bd209f0aa29b0e193e3ab48b9a9"><gtr:id>f12b2bd209f0aa29b0e193e3ab48b9a9</gtr:id><gtr:otherNames>Horrocks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58caab0234d114.84349962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D63DD96E-32B8-4B17-87E0-B94D26FF012A</gtr:id><gtr:title>Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.</gtr:title><gtr:parentPublicationTitle>JAMA psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30d04d3c37a8336900cc57a35737f9de"><gtr:id>30d04d3c37a8336900cc57a35737f9de</gtr:id><gtr:otherNames>Allardyce J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2168-622X</gtr:issn><gtr:outcomeId>5a7dcba6a784a8.93406991</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5242A67-4A3D-48D6-ABA4-1894F5D31D14</gtr:id><gtr:title>Why has therapy development for dementia failed in the last two decades?</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4887f7cb28dbdf7675cc19c781076e6d"><gtr:id>4887f7cb28dbdf7675cc19c781076e6d</gtr:id><gtr:otherNames>Gauthier S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58a4244a088b39.45906762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D60223C-CFD4-4F7A-A41A-F7279AC35A02</gtr:id><gtr:title>BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c738a7cf905389dba329a747a71140a1"><gtr:id>c738a7cf905389dba329a747a71140a1</gtr:id><gtr:otherNames>Lim YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58c7d46dbd7267.70846795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>131E4423-0B2D-4AAF-8480-501F70F22630</gtr:id><gtr:title>Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>585d527f83fd79.94488261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90BEA58F-3D8D-4671-A7B4-C9B76375D0D3</gtr:id><gtr:title>Parent-child relationships and offspring's positive mental wellbeing from adolescence to early older age.</gtr:title><gtr:parentPublicationTitle>The journal of positive psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cb9099b1e4362a3f816884be1ff6356"><gtr:id>7cb9099b1e4362a3f816884be1ff6356</gtr:id><gtr:otherNames>Stafford M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-9760</gtr:issn><gtr:outcomeId>58ca6c8d072b49.60199265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42B626AD-3475-4E16-8FAB-66EC20072CD7</gtr:id><gtr:title>Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.</gtr:title><gtr:parentPublicationTitle>Molecular diagnosis &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b3e20fda70740751de85d30c038b636"><gtr:id>1b3e20fda70740751de85d30c038b636</gtr:id><gtr:otherNames>Keshavan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1177-1062</gtr:issn><gtr:outcomeId>583d585888abe7.15934968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B43884-A876-47C9-A0CF-BA423E2FA367</gtr:id><gtr:title>Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dc1dad1328ff39b9bf6ec30c9ef9435"><gtr:id>5dc1dad1328ff39b9bf6ec30c9ef9435</gtr:id><gtr:otherNames>Lane CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>5a2fd9a90bbdb1.84485772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFF0FF5A-38DF-4D70-B812-AF4B35988513</gtr:id><gtr:title>Intensity and Types of Physical Exercise in Relation to Dementia Risk Reduction in Community-Living Older Adults.</gtr:title><gtr:parentPublicationTitle>Journal of the American Medical Directors Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f37516b1c2d831f39a236d48d26aa4a2"><gtr:id>f37516b1c2d831f39a236d48d26aa4a2</gtr:id><gtr:otherNames>Lee AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1525-8610</gtr:issn><gtr:outcomeId>58ca6c8e64e219.16760737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>033540C1-3126-4BA1-86E8-F0AE0E2B602A</gtr:id><gtr:title>Reliability of an automatic classifier for brain enlarged perivascular spaces burden and comparison with human performance.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9144fd4dea4b04cd72c61daf2a0f29e9"><gtr:id>9144fd4dea4b04cd72c61daf2a0f29e9</gtr:id><gtr:otherNames>Gonz?lez-Castro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>5aa15d344cbf01.01393039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EB47123-D44E-4AFE-806A-D8771A0864EC</gtr:id><gtr:title>Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>585d735d1c8a57.22413378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAEDE0A1-A96C-4CC0-A47D-A24DF77CD2EE</gtr:id><gtr:title>Common schizophrenia alleles are enriched in mutation-intolerant genes and maintained by background selection</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52996edc8e9633f15b51d14b0af26c20"><gtr:id>52996edc8e9633f15b51d14b0af26c20</gtr:id><gtr:otherNames>Pardi?as A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a7dccd4798840.31732227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F0FE480-66AB-4E29-AA29-E86DF584B1DC</gtr:id><gtr:title>Genomic profiling and diagnostic biomarkers in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a7dcba75590b1.27475841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE277787-0FCB-4FF7-869D-E9F4096C32F0</gtr:id><gtr:title>Small vessels, dementia and chronic diseases-molecular mechanisms and pathophysiology.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d4944da6060d033e7b78eb9c8749e1"><gtr:id>a6d4944da6060d033e7b78eb9c8749e1</gtr:id><gtr:otherNames>Wardlaw JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>5aa15c66eb7813.22497238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAC82BB2-1675-4B25-9D73-6D2C91B0F3E6</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease</gtr:title><gtr:parentPublicationTitle>Human Molecular Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5a7dccd5779542.98988380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDDF91BA-B854-4066-9820-BE4D909C9AB6</gtr:id><gtr:title>Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/170bd335c0b34f03eea8d287e42e6829"><gtr:id>170bd335c0b34f03eea8d287e42e6829</gtr:id><gtr:otherNames>Bemelmans SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a7302cd5ef0e8.05207812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F44229B3-6EAF-4352-8882-FD4F8E7C0B6F</gtr:id><gtr:title>Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63525e4b0271aa256b323de26fe8f1"><gtr:id>1e63525e4b0271aa256b323de26fe8f1</gtr:id><gtr:otherNames>Brown BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>5a6f003aa01675.91350346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>835197AC-06B4-411D-87AA-5C7AE09FEB75</gtr:id><gtr:title>Common polygenic variation enhances risk prediction for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56e988d60b6614.55881256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE5DC32A-6F29-4FF2-AB83-F6025E69C970</gtr:id><gtr:title>Physical and cognitive capability in mid-adulthood as determinants of retirement and extended working life in a British cohort study.</gtr:title><gtr:parentPublicationTitle>Scandinavian journal of work, environment &amp; health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cb9099b1e4362a3f816884be1ff6356"><gtr:id>7cb9099b1e4362a3f816884be1ff6356</gtr:id><gtr:otherNames>Stafford M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0355-3140</gtr:issn><gtr:outcomeId>58ca6c8c4d2348.62175645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52F3BB03-C0A1-42A0-BE42-3DC016B4CA49</gtr:id><gtr:title>Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A&amp;nbsp;serial magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22fbaf5051f663328d8f934b07e7676e"><gtr:id>22fbaf5051f663328d8f934b07e7676e</gtr:id><gtr:otherNames>Kinnunen KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>5a6ae63d735cc7.25427532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77E5D10F-2861-4DAD-BBCD-CAE798EB56E8</gtr:id><gtr:title>Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33c1328cae6c1cb519bb5089c3906ed0"><gtr:id>33c1328cae6c1cb519bb5089c3906ed0</gtr:id><gtr:otherNames>Gordon B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa94868983109.36048088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24DD19CF-C612-440C-8C2F-A9A22A532EB8</gtr:id><gtr:title>Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-? Concentration.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a896c05ff079b09bbd8b7d45f25746b3"><gtr:id>a896c05ff079b09bbd8b7d45f25746b3</gtr:id><gtr:otherNames>Toombs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>58a424493a0738.52157919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>843CCB12-5042-434E-B2DC-35D32C7A4CED</gtr:id><gtr:title>Childhood intelligence in relation to major causes of death in 68 year follow-up: prospective population study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1872d0ab47cf74842e3e9d5f1f21fca1"><gtr:id>1872d0ab47cf74842e3e9d5f1f21fca1</gtr:id><gtr:otherNames>Calvin CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a8ffe0d5e61d5.38999834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2CDA368-E29B-4671-A86E-4FA7746EF92E</gtr:id><gtr:title>Polygenic risk score analysis of pathologically confirmed Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5a7dcba7148756.15184932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F6BD84C-0FE3-4E20-A8F3-2CA63F2679FD</gtr:id><gtr:title>Interleukin-10 family cytokines pathway: genetic variants and psoriasis.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87f218ff2212e7edb2c10f16a9843645"><gtr:id>87f218ff2212e7edb2c10f16a9843645</gtr:id><gtr:otherNames>Galimova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>5a7dcfab2d0d99.79831072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5B8D070-DB8A-4977-A75D-5AF0682A2A1E</gtr:id><gtr:title>Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d693375489efc7957bcdc508f2f0d7"><gtr:id>11d693375489efc7957bcdc508f2f0d7</gtr:id><gtr:otherNames>Tang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58a44b38a8d093.91676148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED836E4-3B64-49CB-98D8-81EAF6251747</gtr:id><gtr:title>Poor Balance as a Noncognitive Predictor of Incident Dementia.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f37516b1c2d831f39a236d48d26aa4a2"><gtr:id>f37516b1c2d831f39a236d48d26aa4a2</gtr:id><gtr:otherNames>Lee AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn><gtr:outcomeId>58ca6c8ed55d25.39116226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA9BDEE5-B3D1-467C-B24D-FC883AB04B1D</gtr:id><gtr:title>Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8d2dccb5c3338979e7f8a8641956f6"><gtr:id>0c8d2dccb5c3338979e7f8a8641956f6</gtr:id><gtr:otherNames>Proitsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a7dccd5b1d830.39773145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E3E5653-1951-4349-B66E-3010C21A93EB</gtr:id><gtr:title>The MRC National Survey of Health and Development reaches age 70: maintaining participation at older ages in a birth cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977456e1e88d768cbc2b50dbe3f60187"><gtr:id>977456e1e88d768cbc2b50dbe3f60187</gtr:id><gtr:otherNames>Kuh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn><gtr:outcomeId>58ca6c8c065ad7.99719336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D3BAAFE-0734-4796-8429-021262D8DC65</gtr:id><gtr:title>Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48e1d86cd12b32bc841c95166a835091"><gtr:id>48e1d86cd12b32bc841c95166a835091</gtr:id><gtr:otherNames>Kendall KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>5a7dcfaabbb9e0.63018389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC3FCF50-AAF0-4E27-BA14-8FFBBDF545FB</gtr:id><gtr:title>The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in&amp;nbsp;Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5109e1a98eef0b7d0fee05867d6f9d86"><gtr:id>5109e1a98eef0b7d0fee05867d6f9d86</gtr:id><gtr:otherNames>Morgan AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5a7dcfabae5037.12702221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE92C70C-811B-4FFE-A526-EC263171A3E5</gtr:id><gtr:title>A life course approach to health literacy: the role of gender, educational attainment and lifetime cognitive capability.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3dbfb1dba8b18e178c7bc8b4db2d286"><gtr:id>c3dbfb1dba8b18e178c7bc8b4db2d286</gtr:id><gtr:otherNames>Clouston SAP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>58ca6c8cc9a6d2.34356034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F897F9BE-DC97-45B7-8B35-21F9C8317125</gtr:id><gtr:title>Multimodal Image Analysis in Alzheimer's Disease via Statistical Modelling of Non-local Intensity Correlations.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d410b9903f6823797eb686df00539115"><gtr:id>d410b9903f6823797eb686df00539115</gtr:id><gtr:otherNames>Lorenzi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>583d6c701f17e4.75518920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A849E5-8778-4DF0-B87D-EDF4FA85063D</gtr:id><gtr:title>Direct Parametric Reconstruction With Joint Motion Estimation/Correction for Dynamic Brain PET Data.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dad7d5faaddcd33af62818747e2d0fb"><gtr:id>6dad7d5faaddcd33af62818747e2d0fb</gtr:id><gtr:otherNames>Jiao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn><gtr:outcomeId>58c907f1e1d0e9.47708002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBAF40DC-E94A-4277-8D12-B73965EF3830</gtr:id><gtr:title>Adolescent Self-Organization and Adult Smoking and Drinking over Fifty Years of Follow-Up: The British 1946 Birth Cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/657a517be8ab6fd3040d5bdb9fedead5"><gtr:id>657a517be8ab6fd3040d5bdb9fedead5</gtr:id><gtr:otherNames>Nishida A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58ca6c8de8c871.07606893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D37D0619-6EAF-4330-AFB1-7BC1481C4D11</gtr:id><gtr:title>Psychometric Validation of the Parental Bonding Instrument in a U.K. Population-Based Sample: Role of Gender and Association With Mental Health in Mid-Late Life.</gtr:title><gtr:parentPublicationTitle>Assessment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef76cefd3c4ac54d12d853b654adaaa0"><gtr:id>ef76cefd3c4ac54d12d853b654adaaa0</gtr:id><gtr:otherNames>Xu MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-1911</gtr:issn><gtr:outcomeId>58ca6c8d3d67c0.60417098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73D2F337-751F-47AC-B8E0-52FDD382A088</gtr:id><gtr:title>Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6446838f83f81f804d5ac791f0f7d797"><gtr:id>6446838f83f81f804d5ac791f0f7d797</gtr:id><gtr:otherNames>Weston PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58a44b38dea301.46553282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60A0D807-D090-4118-9DE3-5EDFF27A4319</gtr:id><gtr:title>PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>The journal of prevention of Alzheimer's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62dd352243d69eac75146be22c5ef7bc"><gtr:id>62dd352243d69eac75146be22c5ef7bc</gtr:id><gtr:otherNames>Hampel H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2274-5807</gtr:issn><gtr:outcomeId>5a7dcfab6be1b7.51928771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F53A840-E9CC-4319-9C3C-11ED22E8D2BE</gtr:id><gtr:title>White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c61eff9b24ccc7c0cf635fef61cb3b9"><gtr:id>1c61eff9b24ccc7c0cf635fef61cb3b9</gtr:id><gtr:otherNames>Fiford CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn><gtr:outcomeId>58a42448e22352.63083124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A4D565E-FBF8-405E-A779-9810D126F593</gtr:id><gtr:title>Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6446838f83f81f804d5ac791f0f7d797"><gtr:id>6446838f83f81f804d5ac791f0f7d797</gtr:id><gtr:otherNames>Weston PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>583d5858673fe5.58923759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17196102-08F8-4415-B9D9-B60AED9F30FF</gtr:id><gtr:title>Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4a76348951f17484f8da7816a2728fa"><gtr:id>b4a76348951f17484f8da7816a2728fa</gtr:id><gtr:otherNames>Vilhj?lmsson BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a7dcd68898bb7.22704841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74B38394-E301-4674-AF54-13A22952BF39</gtr:id><gtr:title>A high-fat, high-glycaemic index, low-fibre dietary pattern is prospectively associated with type 2 diabetes in a British birth cohort.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75f8840c01a06c04b84697bb83079db1"><gtr:id>75f8840c01a06c04b84697bb83079db1</gtr:id><gtr:otherNames>Pastorino S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>58ca6c8e2c6691.02371165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F5E5C7E-6DB2-4126-9A66-08B918634C00</gtr:id><gtr:title>Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a9fb87f0aaf08.66735452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3781331E-1588-4BEE-99B4-281FA7A5E1D6</gtr:id><gtr:title>Small vessels, dementia and chronic diseases-molecular mechanisms and pathophysiology.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d4944da6060d033e7b78eb9c8749e1"><gtr:id>a6d4944da6060d033e7b78eb9c8749e1</gtr:id><gtr:otherNames>Wardlaw JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>58c933d00a56a1.24381473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85B55685-B690-41E4-9A95-C6123A2C478E</gtr:id><gtr:title>Shared genetic contribution to Ischaemic Stroke and Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ff905ca396cdd019b10c080a5d07bcb"><gtr:id>4ff905ca396cdd019b10c080a5d07bcb</gtr:id><gtr:otherNames>Traylor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5a7dccd4e54492.20440384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1FBD156-5D99-4A04-BAC1-C485B281EF31</gtr:id><gtr:title>Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98dec3dd03d7f6b588d510785b174431"><gtr:id>98dec3dd03d7f6b588d510785b174431</gtr:id><gtr:otherNames>Dangour AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>58ca6c8e9b6666.93265390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4F70D08-6FB0-44F4-A37C-F0FB3D5F80D6</gtr:id><gtr:title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0feceecb98aa588e6a081c49d40c9ab"><gtr:id>b0feceecb98aa588e6a081c49d40c9ab</gtr:id><gtr:otherNames>Bulik-Sullivan BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a7dccd53514e4.99050233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06BFE79C-B431-4C2F-9277-EE11E012CE58</gtr:id><gtr:title>Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62366058290559ad41281d7f243bbb01"><gtr:id>62366058290559ad41281d7f243bbb01</gtr:id><gtr:otherNames>Schrag A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>583d5857d0c0a5.20101387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DA2AD6B-AE17-435A-A17E-8261A836C1FF</gtr:id><gtr:title>Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b7bc67e86a896d8699dccda7511ae9"><gtr:id>28b7bc67e86a896d8699dccda7511ae9</gtr:id><gtr:otherNames>Andrews KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>585d567d11fa95.40952392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E523E66B-0EE2-4DB3-B7AC-A931D10AB864</gtr:id><gtr:title>Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08df285307de7473b5634cdc0739fbb5"><gtr:id>08df285307de7473b5634cdc0739fbb5</gtr:id><gtr:otherNames>Ward J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>5a7dcba7a6b232.55361658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CD7452C-F0DE-41FA-8DAF-2A6180F0FA67</gtr:id><gtr:title>Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5832c5467c1bd6.02664390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02FE5895-6FC7-4349-A848-957AFA5F961D</gtr:id><gtr:title>The relationship between affective symptoms and hypertension-role of the labelling effect: the 1946 British birth cohort.</gtr:title><gtr:parentPublicationTitle>Open heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44a2861ba8eafe7f78ab35442f583c2d"><gtr:id>44a2861ba8eafe7f78ab35442f583c2d</gtr:id><gtr:otherNames>Tikhonoff V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2053-3624</gtr:issn><gtr:outcomeId>58ca6c8db4a459.58813363</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L023784/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>